Short cuts
Budget warning follows latest NICE drug approvals The National Institute for Clinical Excellence has approved the use of orlistat for obesity and pioglitazone for type-2 diabetes by the NHS in England and Wales. Orlistat may be prescribed to clinically obese adults who also have another serious illness such as high ...
You need to be a subscriber to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All HSJ news by sector, topic & region
- Breaking News announcements
- App for mobile and offline reading
- Comment and Daily Insights newsletters
- Regional roundup newsletters
- 10 expert briefings every fortnight (Premium only)
- Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)
Already a subscriber? Sign into your account here